Athira Pharma (ATHA)
Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its p...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 6.750
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 8.360
- Volume Ratio
- 0.00
- Turnover Ratio
- --
Athira Pharma Analyst Rating
View moreForecast & Rating
Nov 17, 2025Price forecast
$4.00-40.74%
Forecast & RatingHold
2analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · Mar 11 at 04:35 AM
Short Interest in Leonardo S.P.A. - Unsponsored ADR (OTCMKTS:FINMY) Decreases By 60.6%
- benzinga_article · Dec 26, 2025 at 06:05 AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
- Tip Ranks · Dec 18, 2025 at 06:15 PM
Mizuho Securities Sticks to Their Hold Rating for Athira Pharma (ATHA)
- Tip Ranks · Dec 18, 2025 at 03:30 PM
Ligand Pharma Highlights Broad Disclosure of Athira Investment
- benzinga_article · Dec 18, 2025 at 01:17 PM
Why Is Athira Pharma Stock Spiking After Breast Cancer Asset Acquisition?
- Unusual Whales · Dec 18, 2025 at 11:18 AM
Nasdaq gains over 200 points, US inflation slows to 2.7%. Dow up 0.44% to 48,097.08, NASDAQ up 1.08% to 22,938.56, S&P 500 up 0.76% to 6,772.76.
